- Home
- NUWE vs VINC Comparison
NUWE vs VINC Comparison
Compare NUWE & VINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- VINC
- Stock Information
- Founded
- NUWE 1999
- VINC 2019
- Country
- NUWE United States
- VINC United States
- Employees
- NUWE N/A
- VINC N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VINC Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- VINC Health Care
- Exchange
- NUWE Nasdaq
- VINC Nasdaq
- Market Cap
- NUWE 5.2M
- VINC 6.2M
- IPO Year
- NUWE N/A
- VINC N/A
- Fundamental
- Price
- NUWE $1.30
- VINC $1.24
- Analyst Decision
- NUWE Strong Buy
- VINC Buy
- Analyst Count
- NUWE 1
- VINC 2
- Target Price
- NUWE $17.00
- VINC $40.00
- AVG Volume (30 Days)
- NUWE 1.1M
- VINC 1.1M
- Earning Date
- NUWE 03-11-2025
- VINC 03-28-2025
- Dividend Yield
- NUWE N/A
- VINC N/A
- EPS Growth
- NUWE N/A
- VINC N/A
- EPS
- NUWE N/A
- VINC N/A
- Revenue
- NUWE $8,969,000.00
- VINC N/A
- Revenue This Year
- NUWE $2.18
- VINC N/A
- Revenue Next Year
- NUWE $25.75
- VINC N/A
- P/E Ratio
- NUWE N/A
- VINC N/A
- Revenue Growth
- NUWE 3.66
- VINC N/A
- 52 Week Low
- NUWE $0.92
- VINC $1.18
- 52 Week High
- NUWE $26.95
- VINC $187.44
- Technical
- Relative Strength Index (RSI)
- NUWE 52.78
- VINC 28.95
- Support Level
- NUWE $1.17
- VINC $1.18
- Resistance Level
- NUWE $1.48
- VINC $1.38
- Average True Range (ATR)
- NUWE 0.09
- VINC 0.11
- MACD
- NUWE 0.01
- VINC 0.09
- Stochastic Oscillator
- NUWE 45.45
- VINC 12.50
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.